According to Wave Life Sciences's latest financial reports the company has a price-to-book ratio of 19.0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 15.2 | -212.52% |
2022-12-31 | -13.5 | -333.35% |
2021-12-31 | 5.78 | 24.68% |
2020-12-31 | 4.64 | 7.38% |
2019-12-31 | 4.32 | -74.43% |
2018-12-31 | 16.9 | 141.77% |
2017-12-31 | 6.99 | 53.49% |
2016-12-31 | 4.55 | 103.25% |
2015-12-31 | 2.24 | |
2014-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.92 | -84.58% | ๐บ๐ธ USA |